[HTML] frontiersin.org

[HTML][HTML] Shortcomings in the current amyotrophic lateral sclerosis trials and potential solutions for improvement

N Katyal, R Govindarajan - Frontiers in neurology, 2017 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome
predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone …
被引用次数：43 相关文章

Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.

N Katyal, R Govindarajan - Frontiers in Neurology, 2017 - europepmc.org
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome
predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone …

Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement

N Katyal, R Govindarajan - Frontiers in neurology, 2017 - pubmed.ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome
predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone …
[HTML] nih.gov

[HTML][HTML] Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement

N Katyal, R Govindarajan - Frontiers in Neurology, 2017 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome
predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone …

Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.

N Katyal, R Govindarajan - Frontiers in Neurology, 2017 - europepmc.org
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome
predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone …